CompanyDeals

Harbour BioMed Licenses HBM4003 to Solstice Oncology in $1.2B+ Deal – Expands Global Footprint for CTLA‑4 Asset

CompanyDrug

CSPC Pharmaceutical Wins NMPA Approval for Phase II Study of SYS6023 HER3 ADC in Metastatic Breast Cancer

Trinomab's Retavibart NDA Accepted by NMPA – First Long‑Acting RSV mAb for Infant Protection in China
Others

Trinomab’s Retavibart NDA Accepted by NMPA – First Long‑Acting RSV mAb for Infant Protection in China

CompanyDrug

Sichuan Biokin’s Iza‑Bren Hits PFS and OS Endpoints in Phase III TNBC Study – First Bispecific ADC to Show Dual Survival Benefit

FDA Issues Draft Guidance on Plausible Mechanism Framework – Accelerates Approval Pathway for Individualized Genetic Therapies
Policy / Regulatory

FDA Issues Draft Guidance on Plausible Mechanism Framework – Accelerates Approval Pathway for Individualized Genetic Therapies

Gilead Sciences to Acquire Arcellx for $7.8B – Bolsters CAR‑T Pipeline with BCMA‑Targeted Anito‑cel
CompanyDeals

Gilead Sciences to Acquire Arcellx for $7.8B – Bolsters CAR‑T Pipeline with BCMA‑Targeted Anito‑cel

Company

Pfizer Partners with Sciwind Biosciences for Ecnoglutide China Rights – $495M Deal Marks Metabolic Market Entry

Merck Restructures Human Health into Oncology and Specialty Units – Appoints Oosthuizen and Foard to Lead New Divisions
Company

Merck Restructures Human Health into Oncology and Specialty Units – Appoints Oosthuizen and Foard to Lead New Divisions

Sino Biopharma's Benmelstobart Secures Fourth NMPA Approval for Stage III NSCLC – Expanding PD‑L1 Franchise in China
CompanyDrug

Sino Biopharma’s Benmelstobart Secures Fourth NMPA Approval for Stage III NSCLC – Expanding PD‑L1 Franchise in China

Mabworks’ Obexelimab β Wins NMPA Approval as First Domestic NMOSD Therapy
CompanyDrug

Mabworks’ Obexelimab β Wins NMPA Approval as First Domestic NMOSD Therapy

Findcure Bio Raises $14.5 Million Series B to Advance Radiopharmaceutical Platform
CompanyDeals

Findcure Bio Raises $14.5 Million Series B to Advance Radiopharmaceutical Platform

Siemens Healthineers Deepens Mayo Clinic Partnership on AI Neurology and Precision Oncology
CompanyDeals

Siemens Healthineers Deepens Mayo Clinic Partnership on AI Neurology and Precision Oncology